D 4559
Alternative Names: D-4559Latest Information Update: 20 Apr 2023
At a glance
- Originator Ashvattha Therapeutics
- Class Antineoplastics; Dendrimers
- Mechanism of Action Macrophage modulators; Vascular endothelial growth factor receptor-1 antagonists; Vascular endothelial growth factor receptor-2 antagonists; Vascular endothelial growth factor receptor-3 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Liver cancer